A nerve-stimulation treatment for obstructive sleep apnea that originally was approved only for people with body mass indexes (BMIs) in the healthy range recently was extended to patients with BMIs up to 40, a weight range generally described as severely obese.
FDA to import more of cancer drug from China
The US is planning to import more doses of the chemotherapy cisplatin that is still in short supply. A spokesperson for Apotex, a generic medicine